Skip to main content
TipRanks
Go Ultimate75% OFF

Radiopharm Theranostics Limited (RAD) Ratios

25 Followers

Radiopharm Theranostics Limited Ratios

AU:RAD's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, AU:RAD's free cash flow was increased by AU$30.11M and operating cash flow was AU$-30.11M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio1.162.671.301.233.46
Quick Ratio1.162.671.301.233.46
Cash Ratio0.221.951.060.883.42
Solvency Ratio-1.46-0.78-1.00-1.07-1.34
Operating Cash Flow Ratio-2.79-2.45-1.31-1.75-1.26
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset ValueAU$ -15.88MAU$ -3.76MAU$ -21.83MAU$ -13.07MAU$ 6.85M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio2.441.932.561.691.32
Debt Service Coverage Ratio-607.38-486.22-70.73-431.47-1.93
Interest Coverage Ratio-607.93-584.59-73.43-468.02-2.13
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.000.000.03
Net Debt to EBITDA0.060.920.410.321.50
Profitability Margins
Gross Profit Margin-77.67%73.18%-7121.04%-1027.56%-33661.57%
EBIT Margin-2468.61%-255.53%-16209.19%-13820.19%-237174.08%
EBITDA Margin-2468.35%-236.16%-15164.41%-12692.63%-204330.06%
Operating Profit Margin-2468.61%-284.87%-15777.22%-13781.81%-225527.71%
Pretax Profit Margin-2055.58%-285.36%-15992.07%-13849.64%-343048.15%
Net Profit Margin-1992.46%-273.90%-16024.28%-11838.59%-343550.89%
Continuous Operations Profit Margin-2053.61%-286.13%-16024.28%-11838.59%-343550.89%
Net Income Per EBT96.93%95.98%100.20%85.48%100.15%
EBT Per EBIT83.27%100.17%101.36%100.49%152.11%
Return on Assets (ROA)-91.71%-42.44%-66.56%-46.18%-36.39%
Return on Equity (ROE)-223.39%-81.94%-170.50%-77.98%-48.19%
Return on Capital Employed (ROCE)-165.70%-53.35%-86.69%-65.28%-26.38%
Return on Invested Capital (ROIC)-165.54%-53.35%-86.69%-65.28%-26.38%
Return on Tangible Assets-251.00%-91.97%-208.94%-210.94%-111.11%
Earnings Yield-81.90%-80.00%-326.51%-114.12%-81.05%
Efficiency Ratios
Receivables Turnover0.161.290.300.070.16
Payables Turnover0.900.573.361.122.51
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover59.99250.634.924.285.60
Asset Turnover0.050.150.000.000.00
Working Capital Turnover Ratio0.200.890.070.030.00
Cash Conversion Cycle1895.06-361.331095.765250.672188.86
Days of Sales Outstanding2300.78283.281204.455578.032334.50
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding405.72644.60108.69327.35145.64
Operating Cycle2300.78283.281204.455578.032334.50
Cash Flow Ratios
Operating Cash Flow Per Share-0.01-0.02-0.06-0.07-0.04
Free Cash Flow Per Share0.00-0.02-0.06-0.08-0.14
Dividend Paid and CapEx Coverage Ratio-1.000.00-4595187.00-15.16-0.35
Capital Expenditure Coverage Ratio-1.000.00-4595187.00-15.16-0.35
Operating Cash Flow Coverage Ratio0.000.000.000.000.00
Operating Cash Flow to Sales Ratio-19.07-2.73-76.78-79.36-1121.82
Free Cash Flow Yield0.00%-79.87%-156.45%-81.55%-102.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.22-1.25-0.31-0.88-1.23
Price-to-Sales (P/S) Ratio24.333.4249.08103.744238.84
Price-to-Book (P/B) Ratio2.731.020.520.680.59
Price-to-Free Cash Flow (P/FCF) Ratio0.00-1.25-0.64-1.23-0.98
Price-to-Operating Cash Flow Ratio-1.28-1.25-0.64-1.31-3.78
Price-to-Earnings Growth (PEG) Ratio0.110.01-0.030.00-0.00
Enterprise Value Multiple-0.93-0.530.09-0.50-0.58
Enterprise Value63.20M16.76M-3.89M18.63M10.45M
EV to EBITDA-0.93-0.530.09-0.50-0.58
EV to Sales22.831.25-13.0063.721183.79
EV to Free Cash Flow0.00-0.460.17-0.75-0.27
EV to Operating Cash Flow-1.20-0.460.17-0.80-1.06
Tangible Book Value Per Share-0.00-0.00-0.06-0.040.02
Shareholders’ Equity Per Share0.010.020.070.140.23
Tax and Other Ratios
Effective Tax Rate0.00-0.00-0.00-0.00-0.00
Revenue Per Share0.000.010.000.000.00
Net Income Per Share-0.02-0.02-0.12-0.11-0.11
Tax Burden0.970.961.000.851.00
Interest Burden0.831.120.991.001.45
Research & Development to Revenue18.052.0558.6875.34847.77
SG&A to Revenue5.861.2343.5844.541408.51
Stock-Based Compensation to Revenue0.000.148.8210.39543.62
Income Quality0.961.000.480.670.33

Currency in AUD